1-4 of 4
Sentiljana Gumeni
Close
Sort by
Journal Articles

Booster BNT162b2 optimizes SARS-CoV-2 humoral response in patients with myeloma: the negative effect of anti-BCMA therapy

Clinical Trials & Observations
Evangelos Terpos, Maria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos, Alexandros Briasoulis, Sentiljana Gumeni, Panagiotis Malandrakis, Eleni-Dimitra Papanagnou, Magdalini Migkou, Nikolaos Kanellias, Efstathios Kastritis, Ioannis P. Trougakos, Meletios A. Dimopoulos
Journal: Blood
Blood (2022) 139 (9): 1409–1412.
https://doi.org/10.1182/blood.2021014989
Published: 2022
Includes: Supplemental data
Journal Articles

Patients with Multiple Myeloma on Anti-CD38 or Anti-BCMA Based Regimens and Patients with Waldenstrom's Macroglobulinemia Under Rituximab or BTK Inhibitors Have a Poor Humoral Response Following COVID-19 Vaccination

Evangelos Terpos, Maria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos, Alexandros Briasoulis, Sentiljana Gumeni, Panagiotis Malandrakis, Despina Fotiou, Eleni-Dimitra Papanagnou, Magdalini Migkou, Foteini Theodorakakou, Maria Roussou, Evangelos Eleutherakis-Papaiakovou, Nikolaos Kanellias, Ioannis P. Trougakos, Efstathios Kastritis, Meletios-Athanasios Dimopoulos
Journal: Blood
Blood (2021) 138 (Supplement 1): 3791.
https://doi.org/10.1182/blood-2021-144856
Published: 2021
Journal Articles

Patients with Multiple Myeloma and Prior COVID-19 Have Superior Antibody Responses Against Sars-Cov-2 Compared with Fully Vaccinated Myeloma Patients with the BNT162b2 Vaccine

Maria Gavriatopoulou, Evangelos Terpos, Panagiotis Malandrakis, Ioannis Ntanasis-Stathopoulos, Alexandros Briasoulis, Sentiljana Gumeni, Despina Fotiou, Eleni-Dimitra Papanagnou, Magdalini Migkou, Foteini Theodorakakou, Evangelos Eleutherakis-Papaiakovou, Nikolaos Kanellias, Ioannis P. Trougakos, Efstathios Kastritis, Meletios-Athanasios Dimopoulos
Journal: Blood
Blood (2021) 138 (Supplement 1): 3802.
https://doi.org/10.1182/blood-2021-145487
Published: 2021
Journal Articles

Kinetics of Anti-Sars-Cov-2 Antibody Responses 3 Months Post Complete Vaccination with BNT162b2; A Prospective Study in 283 Health Workers

Evangelos Terpos, Ioannis P. Trougakos, Vangelis Karalis, Ioannis Ntanasis-Stathopoulos, Filia Apostolakou, Sentiljana Gumeni, Aimilia D. Sklirou, Stamatia Skourti, Maria Gavriatopoulou, Efstathios Kastritis, Eleni Korompoki, Ioannis Papassotiriou, Meletios A. Dimopoulos
Journal: Blood
Blood (2021) 138 (Supplement 1): 4202.
https://doi.org/10.1182/blood-2021-145074
Published: 2021